NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 160 filers reported holding NEVRO CORP in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $339 | -1.2% | 17,632 | +30.6% | 0.00% | – |
| Q2 2023 | $343 | -56.8% | 13,499 | -38.5% | 0.00% | – |
| Q1 2023 | $794 | -40.0% | 21,957 | -34.3% | 0.00% | – |
| Q4 2022 | $1,324 | -99.0% | 33,441 | +1067.6% | 0.00% | – |
| Q3 2022 | $134,000 | +52.3% | 2,864 | +43.5% | 0.00% | – |
| Q2 2022 | $88,000 | -82.5% | 1,996 | -71.3% | 0.00% | – |
| Q1 2022 | $503,000 | -98.8% | 6,944 | -98.6% | 0.00% | -100.0% |
| Q4 2021 | $41,056,000 | +466.4% | 506,416 | +713.1% | 0.01% | +166.7% |
| Q3 2021 | $7,248,000 | +80.9% | 62,284 | +157.8% | 0.00% | +50.0% |
| Q2 2021 | $4,007,000 | -36.6% | 24,164 | -46.7% | 0.00% | -33.3% |
| Q1 2021 | $6,324,000 | -47.7% | 45,330 | -35.1% | 0.00% | -50.0% |
| Q4 2020 | $12,085,000 | +159.3% | 69,817 | +108.6% | 0.01% | +100.0% |
| Q3 2020 | $4,661,000 | +28.2% | 33,466 | +10.0% | 0.00% | 0.0% |
| Q2 2020 | $3,636,000 | +256.5% | 30,426 | +198.5% | 0.00% | +200.0% |
| Q1 2020 | $1,020,000 | -71.0% | 10,194 | -65.9% | 0.00% | -50.0% |
| Q4 2019 | $3,519,000 | +41.3% | 29,936 | +3.4% | 0.00% | 0.0% |
| Q3 2019 | $2,490,000 | +101.3% | 28,953 | +51.8% | 0.00% | +100.0% |
| Q2 2019 | $1,237,000 | +127.8% | 19,069 | +119.2% | 0.00% | – |
| Q1 2019 | $543,000 | -87.7% | 8,699 | -92.4% | 0.00% | -100.0% |
| Q4 2018 | $4,423,000 | +16.5% | 113,726 | +70.7% | 0.00% | 0.0% |
| Q3 2018 | $3,797,000 | -2.4% | 66,630 | +36.7% | 0.00% | 0.0% |
| Q2 2018 | $3,891,000 | +146.0% | 48,732 | +166.8% | 0.00% | +200.0% |
| Q1 2018 | $1,582,000 | +2.8% | 18,263 | -18.1% | 0.00% | 0.0% |
| Q4 2017 | $1,539,000 | +256.2% | 22,305 | +367.9% | 0.00% | – |
| Q3 2017 | $432,000 | -48.8% | 4,767 | -57.9% | 0.00% | -100.0% |
| Q2 2017 | $843,000 | -56.7% | 11,323 | -45.5% | 0.00% | -50.0% |
| Q1 2017 | $1,947,000 | +6613.8% | 20,786 | +5122.6% | 0.00% | – |
| Q4 2016 | $29,000 | -99.5% | 398 | -99.3% | 0.00% | -100.0% |
| Q3 2016 | $5,632,000 | +565.7% | 53,957 | +370.4% | 0.01% | +500.0% |
| Q2 2016 | $846,000 | +84500.0% | 11,470 | +49769.6% | 0.00% | – |
| Q1 2016 | $1,000 | -99.9% | 23 | -99.9% | 0.00% | -100.0% |
| Q4 2015 | $1,096,000 | +27300.0% | 16,355 | +18698.9% | 0.00% | – |
| Q3 2015 | $4,000 | -99.9% | 87 | -99.9% | 0.00% | -100.0% |
| Q2 2015 | $6,428,000 | +49346.2% | 121,291 | +44166.8% | 0.01% | – |
| Q1 2015 | $13,000 | -48.0% | 274 | -58.1% | 0.00% | – |
| Q4 2014 | $25,000 | – | 654 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 403,424 | $46,950,000 | 6.74% |
| HealthCor Management, L.P. | 529,230 | $61,592,000 | 2.66% |
| Sante Capital Fund, LP | 18,963 | $2,207,000 | 2.04% |
| Jackson Square Partners, LLC | 2,452,497 | $285,421,000 | 1.81% |
| Altium Capital Management LP | 51,000 | $5,935,000 | 1.56% |
| Rock Springs Capital Management LP | 635,700 | $73,983,000 | 1.56% |
| PFM Health Sciences, LP | 392,786 | $45,712,000 | 1.34% |
| Redmile Group, LLC | 542,932 | $63,186,000 | 1.10% |
| Connacht Asset Management LP | 13,555 | $1,578,000 | 1.02% |
| Integral Health Asset Management, LLC | 30,000 | $3,491,000 | 1.00% |